Quest Diagnostics Incorporated , the nation's leading provider of diagnostic testing, information and services, announced that Kenneth R. Finnegan, Vice President Business Development, is scheduled to speak at the Banc of America Securities Healthcare Conference on Tuesday, April 2, 2002, at the Four Seasons Hotel, Las Vegas, Nevada. The Quest Diagnostics presentation is scheduled to begin at 1:30 p.m. Pacific Time.
The presentation will be audio webcast live during the conference and will be available to registered analysts on the Banc of America Securities' password secured site on the Internet at: http://www.veracast.com/webcasts/BAS/healthcare-2002/id96109461.cmf. All others may access the Quest Diagnostics website at: http://www.questdiagnostics.com/. In addition, the archived webcast will be available through Friday, April 19, 2002, at 5 p.m. Pacific Time.
Quest Diagnostics Incorporated is the nation's leading provider of diagnostic testing, information and services, providing insights that enable physicians, hospitals, managed care organizations and other healthcare professionals to make decisions to improve health. The company offers the broadest access to diagnostic laboratory services through its national network of laboratories and patient service centers. Quest Diagnostics is the leading provider of esoteric testing, including gene-based medical testing, and empowers healthcare organizations and clinicians with state-of-the-art connectivity solutions that improve practice management. Additional company information can be found on the Internet at: http://www.questdiagnostics.com/.
The statements in this press release which are not historical facts or information may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome to be materially different. Certain of these risks and uncertainties are listed in the Quest Diagnostics Incorporated 2000 Form 10-K and subsequent filings.
SOURCE: Quest Diagnostics Incorporated
Contact: Gary Samuels, Media, +1-201-393-5700, or Cathy Doherty,
Investors, +1-201-393-5030, both of Quest Diagnostics Incorporated